An SSA - Search Results

1

The potential anti-amyloidogenic candidate, SPA1413, for Alzheimer's disease.

An SSA, Shim KH, Kang S, Kim YK, Subedi L, Cho H, Hong SM, Tan MA, Jeon R, Chang KA, Kim SY. An SSA, et al. Br J Pharmacol. 2022 Mar;179(5):1033-1048. doi: 10.1111/bph.15691. Epub 2021 Nov 4. Br J Pharmacol. 2022. PMID: 34610141 Free article.

2

The genetics of Alzheimer's disease.

Bagyinszky E, Youn YC, An SS, Kim S. Bagyinszky E, et al. Clin Interv Aging. 2014 Apr 1;9:535-51. doi: 10.2147/CIA.S51571. eCollection 2014. Clin Interv Aging. 2014. PMID: 24729694 Free PMC article. Review.

3

Analysis of SiO2 nanoparticles binding proteins in rat blood and brain homogenate.

Shim KH, Hulme J, Maeng EH, Kim MK, An SS. Shim KH, et al. Int J Nanomedicine. 2014 Dec 15;9 Suppl 2(Suppl 2):207-15. doi: 10.2147/IJN.S58203. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25565838 Free PMC article.

4

Analysis of zinc oxide nanoparticles binding proteins in rat blood and brain homogenate.

Shim KH, Hulme J, Maeng EH, Kim MK, An SS. Shim KH, et al. Int J Nanomedicine. 2014 Nov 15;9 Suppl 2(Suppl 2):217-24. doi: 10.2147/IJN.S58204. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25565839 Free PMC article.

5

Assessment of ZnO and SiO2 nanoparticle permeability through and toxicity to the blood-brain barrier using Evans blue and TEM.

Shim KH, Jeong KH, Bae SO, Kang MO, Maeng EH, Choi CS, Kim YR, Hulme J, Lee EK, Kim MK, An SS. Shim KH, et al. Int J Nanomedicine. 2014 Dec 15;9 Suppl 2(Suppl 2):225-33. doi: 10.2147/IJN.S58205. eCollection 2014. Int J Nanomedicine. 2014. PMID: 25565840 Free PMC article.

6

Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders.

Cai Y, An SS, Kim S. Cai Y, et al. Clin Interv Aging. 2015 Jul 14;10:1163-72. doi: 10.2147/CIA.S85808. eCollection 2015. Clin Interv Aging. 2015. PMID: 26203236 Free PMC article. Review.

7

Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis.

Bagyinszky E, Giau VV, Shim K, Suk K, An SSA, Kim S. Bagyinszky E, et al. Among authors: an ssa. J Neurol Sci. 2017 May 15;376:242-254. doi: 10.1016/j.jns.2017.03.031. Epub 2017 Mar 22. J Neurol Sci. 2017. PMID: 28431620 Review.

8

Genome-editing applications of CRISPR-Cas9 to promote in vitro studies of Alzheimer's disease.

Giau VV, Lee H, Shim KH, Bagyinszky E, An SSA. Giau VV, et al. Among authors: an ssa. Clin Interv Aging. 2018 Feb 7;13:221-233. doi: 10.2147/CIA.S155145. eCollection 2018. Clin Interv Aging. 2018. PMID: 29445268 Free PMC article. Review.

9

Mitochondrial therapeutic interventions in Alzheimer's disease.

Van Giau V, An SSA, Hulme JP. Van Giau V, et al. Among authors: an ssa. J Neurol Sci. 2018 Dec 15;395:62-70. doi: 10.1016/j.jns.2018.09.033. Epub 2018 Sep 28. J Neurol Sci. 2018. PMID: 30292965 Review.

10

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer's disease.

Youn YC, Kang S, Suh J, Park YH, Kang MJ, Pyun JM, Choi SH, Jeong JH, Park KW, Lee HW, An SSA, Dominguez JC, Kim S. Youn YC, et al. Among authors: an ssa. Alzheimers Res Ther. 2019 May 10;11(1):40. doi: 10.1186/s13195-019-0499-7. Alzheimers Res Ther. 2019. PMID: 31077246 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters